Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 98

1.

Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment.

Verrecchia F, Rédini F.

Front Oncol. 2018 Apr 30;8:133. doi: 10.3389/fonc.2018.00133. eCollection 2018. Review.

2.

Implication of molecular vascular smooth muscle cell heterogeneity among arterial beds in arterial calcification.

Espitia O, Chatelais M, Steenman M, Charrier C, Maurel B, Georges S, Houlgatte R, Verrecchia F, Ory B, Lamoureux F, Heymann D, Gouëffic Y, Quillard T.

PLoS One. 2018 Jan 26;13(1):e0191976. doi: 10.1371/journal.pone.0191976. eCollection 2018.

3.

Connexin43 intercellular communication drives the early differentiation of human bone marrow stromal cells into osteoblasts.

Talbot J, Brion R, Lamora A, Mullard M, Morice S, Heymann D, Verrecchia F.

J Cell Physiol. 2018 Feb;233(2):946-957. doi: 10.1002/jcp.25938. Epub 2017 May 23.

PMID:
28369869
4.

Analysis of gap junctional intercellular communications using a dielectrophoresis-based microchip.

Tellez-Gabriel M, Charrier C, Brounais-Le Royer B, Mullard M, Brown HK, Verrecchia F, Heymann D.

Eur J Cell Biol. 2017 Mar;96(2):110-118. doi: 10.1016/j.ejcb.2017.01.003. Epub 2017 Feb 6.

5.

Bone Morphogenetic Protein 2 and Transforming Growth Factor β1 Inhibit the Expression of the Proinflammatory Cytokine IL-34 in Rheumatoid Arthritis Synovial Fibroblasts.

Chemel M, Brion R, Segaliny AI, Lamora A, Charrier C, Brulin B, Maugars Y, Le Goff B, Heymann D, Verrecchia F.

Am J Pathol. 2017 Jan;187(1):156-162. doi: 10.1016/j.ajpath.2016.09.015. Epub 2016 Nov 17.

6.

TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression.

Lamora A, Talbot J, Mullard M, Brounais-Le Royer B, Redini F, Verrecchia F.

J Clin Med. 2016 Nov 3;5(11). pii: E96. Review.

7.

Enhanced detection of terrestrial gamma-ray flashes by AGILE.

Marisaldi M, Argan A, Ursi A, Gjesteland T, Fuschino F, Labanti C, Galli M, Tavani M, Pittori C, Verrecchia F, D'Amico F, Østgaard N, Mereghetti S, Campana R, Cattaneo PW, Bulgarelli A, Colafrancesco S, Dietrich S, Longo F, Gianotti F, Giommi P, Rappoldi A, Trifoglio M, Trois A.

Geophys Res Lett. 2015 Nov 16;42(21):9481-9487. Epub 2015 Nov 6.

8.

Evolution of serum cytokine profile after hematopoietic stem cell transplantation in systemic sclerosis patients.

Michel L, Farge D, Baraut J, Marjanovic Z, Jean-Louis F, Porcher R, Grigore EI, Deligny C, Romijn F, Arruda LC, van Pelt J, Levarht N, Verrecchia F, van Laar JM.

Bone Marrow Transplant. 2016 Aug;51(8):1146-9. doi: 10.1038/bmt.2016.77. Epub 2016 Apr 4. No abstract available.

PMID:
27042845
9.

ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis.

Rodriguez Calleja L, Jacques C, Lamoureux F, Baud'huin M, Tellez Gabriel M, Quillard T, Sahay D, Perrot P, Amiaud J, Charrier C, Brion R, Lecanda F, Verrecchia F, Heymann D, Ellisen LW, Ory B.

Cancer Res. 2016 Jun 1;76(11):3236-51. doi: 10.1158/0008-5472.CAN-15-2317. Epub 2016 Mar 17.

10.

Blocking HSP90 Addiction Inhibits Tumor Cell Proliferation, Metastasis Development, and Synergistically Acts with Zoledronic Acid to Delay Osteosarcoma Progression.

Ory B, Baud'huin M, Verrecchia F, Royer BB, Quillard T, Amiaud J, Battaglia S, Heymann D, Redini F, Lamoureux F.

Clin Cancer Res. 2016 May 15;22(10):2520-33. doi: 10.1158/1078-0432.CCR-15-1925. Epub 2015 Dec 28.

11.

Transforming growth factor-β increases interleukin-13 synthesis via GATA-3 transcription factor in T-lymphocytes from patients with systemic sclerosis.

Baraut J, Farge D, Jean-Louis F, Masse I, Grigore EI, Arruda LC, Lamartine J, Verrecchia F, Michel L.

Arthritis Res Ther. 2015 Jul 31;17:196. doi: 10.1186/s13075-015-0708-0.

12.

Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases.

Lamora A, Mullard M, Amiaud J, Brion R, Heymann D, Redini F, Verrecchia F.

Oncotarget. 2015 Jun 10;6(16):14413-27.

13.

Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.

Mozzillo N, Pasquali S, Santinami M, Testori A, Di Marzo M, Crispo A, Patuzzo R, Verrecchia F, Botti G, Montella M, Rossi CR, Caracò C.

Eur J Surg Oncol. 2015 Jul;41(7):823-9. doi: 10.1016/j.ejso.2015.02.005. Epub 2015 Mar 11.

PMID:
25800935
14.

Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma: a phase II study.

Ferrucci PF, Minchella I, Mosconi M, Gandini S, Verrecchia F, Cocorocchio E, Passoni C, Pari C, Testori A, Coco P, Munzone E.

Melanoma Res. 2015 Jun;25(3):239-45. doi: 10.1097/CMR.0000000000000146.

PMID:
25746039
15.

Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma.

Lamora A, Talbot J, Bougras G, Amiaud J, Leduc M, Chesneau J, Taurelle J, Stresing V, Le Deley MC, Heymann MF, Heymann D, Redini F, Verrecchia F.

Clin Cancer Res. 2014 Oct 1;20(19):5097-112. doi: 10.1158/1078-0432.CCR-13-3191. Epub 2014 Aug 8.

16.

[Sixty years of Pathologie Biologie].

Farge-Bancel D, Verrecchia F, Robert L, Morinet F.

Pathol Biol (Paris). 2014 Apr;62(2):59. doi: 10.1016/j.patbio.2014.02.004. Epub 2014 Mar 20. French. No abstract available.

PMID:
24656440
17.

Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study.

Baraut J, Grigore EI, Jean-Louis F, Khelifa SH, Durand C, Verrecchia F, Farge D, Michel L.

Bone Marrow Transplant. 2014 Mar;49(3):349-54. doi: 10.1038/bmt.2013.202. Epub 2013 Dec 23.

PMID:
24362364
18.

Sentinel node biopsy in thin and thick melanoma.

Mozzillo N, Pennacchioli E, Gandini S, Caracò C, Crispo A, Botti G, Lastoria S, Barberis M, Verrecchia F, Testori A.

Ann Surg Oncol. 2013 Aug;20(8):2780-6. doi: 10.1245/s10434-012-2826-0. Epub 2013 May 30.

PMID:
23720068
19.

A Disintegrin And Metalloproteinase 12 produced by tumour cells accelerates osteosarcoma tumour progression and associated osteolysis.

Georges S, Chesneau J, Hervouet S, Taurelle J, Gouin F, Redini F, Padrines M, Heymann D, Fortun Y, Verrecchia F.

Eur J Cancer. 2013 Jun;49(9):2253-63. doi: 10.1016/j.ejca.2013.02.020. Epub 2013 Mar 13.

PMID:
23490646
20.

Loss of connexin43 expression in Ewing's sarcoma cells favors the development of the primary tumor and the associated bone osteolysis.

Talbot J, Brion R, Picarda G, Amiaud J, Chesneau J, Bougras G, Stresing V, Tirode F, Heymann D, Redini F, Verrecchia F.

Biochim Biophys Acta. 2013 Apr;1832(4):553-64. doi: 10.1016/j.bbadis.2013.01.001. Epub 2013 Jan 9.

Supplemental Content

Loading ...
Support Center